PLCD1 expression for early detection and prognosis in High-Grade serous ovarian cancer
PLCD1 functions as a tumor suppressor in HGSOC and is associated with improved clinical outcomes. These findings suggest that PLCD1 may serve as a prognostic biomarker and potential therapeutic target in ovarian cancer.
Authors
- Jue Young Kim (ORCID: https://orcid.org/0000-0001-8456-1101)
- Razaul Haque
- Eun‐Suk Kang (ORCID: https://orcid.org/0000-0001-6386-6520)
- Jae‐Hoon Kim (ORCID: https://orcid.org/0000-0001-9114-1375)
- Ha‐Yeon Shin (ORCID: https://orcid.org/0000-0001-6735-1700)
Institutions
- Yonsei University (KR)
- Samsung Medical Center (KR)
- Gangnam Severance Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1186/s12885-025-15002-1
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- National Institutes of Health